Vaccí de Minhai contra la COVID-19
| Dades clíniques | |
|---|---|
| Grup farmacològic | vaccí contra la COVID-19 i vacuna inactivada  |
El vaccí de Minhai contra la COVID-19 és un vaccí contra la COVID-19 basat en virus inactivat desenvolupada per la Minhai Biotechnology Co. i la Kangtai Biological Products Co. Ltd.[1][2][3]
Autoritzacions
Referències
- ↑ «A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)». United States National Library of Medicine.
- ↑ «A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)». United States National Library of Medicine.
- ↑ «A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19)». United States National Library of Medicine.
- ↑ Co.,Ltd, Shenzhen Kangtai Biological Products. «BioKangtai's adenovirus vector COVID-19 vaccine obtained EUA in Indonesia» (en anglès). [Consulta: 30 novembre 2021].
- ↑ Staff, Reuters «Kangtai Biological's COVID-19 vaccine gets emergency use approval in China» (en anglès). Reuters, 14-05-2021 [Consulta: 20 maig 2021].
COVID-19 i la Pandèmia de COVID-19 | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||
